Fintel reports that on January 30, 2025, Oppenheimer initiated coverage of Alumis (NasdaqGS:ALMS) with a Outperform recommendation.
Analyst Price Forecast Suggests 356.72% Upside
As of January 29, 2025, the average one-year price target for Alumis is $30.60/share. The forecasts range from a low of $25.25 to a high of $39.90. The average price target represents an increase of 356.72% from its latest reported closing price of $6.70 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual non-GAAP EPS is -6.33.
What is the Fund Sentiment?
There are 126 funds or institutions reporting positions in Alumis. This is an increase of 90 owner(s) or 250.00% in the last quarter. Average portfolio weight of all funds dedicated to ALMS is 1.43%, an increase of 78.15%. Total shares owned by institutions increased in the last three months by 24.32% to 35,540K shares.
What are Other Shareholders Doing?
AyurMaya Capital Management Company holds 10,646K shares. No change in the last quarter.
Foresite Capital Management V holds 5,585K shares. In its prior filing, the firm reported owning 5,585K shares , representing an increase of 0.00%. The firm decreased its portfolio allocation in ALMS by 12.60% over the last quarter.
Samsara BioCapital holds 3,266K shares.
venBio Partners holds 2,826K shares. No change in the last quarter.
Cormorant Asset Management holds 2,147K shares. In its prior filing, the firm reported owning 2,147K shares , representing a decrease of 0.00%. The firm decreased its portfolio allocation in ALMS by 26.29% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
